» Articles » PMID: 38553570

Secondhand Smoke Increases the Risk of Developing Chronic Obstructive Pulmonary Disease

Overview
Journal Sci Rep
Specialty Science
Date 2024 Mar 30
PMID 38553570
Authors
Affiliations
Soon will be listed here.
Abstract

Smoking is the most important risk factor for chronic obstructive pulmonary disease (COPD), however evidence from large-scale studies on whether secondhand smoke (SHS) increases the risk of COPD is still lacking. We conducted this large longitudinal study to investigate the association between SHS and the development of COPD. This is a longitudinal study. Data on 6519 subjects who were never-smokers, had no history of COPD, and had complete lung function records were extracted from the Taiwan Biobank. They were divided into two groups according to SHS exposure: no exposure and exposure groups. Data were collected when participants enrolled in the study and during regular follow-up. Cox proportional hazards regression models were used to estimate the relative risk (RR) and 95% confidence interval (CI) for the association between SHS and the risk of developing COPD. At 48 months of follow-up, 260 (4%) participants in the no exposure group and 34 (7%) participants in the exposure group developed COPD. The RR of incident COPD development was significantly higher in the exposure group than that in the no exposure group after adjusting for confounders (RR = 1.49; 95% CI 1.04 to 2.14; P value = 0.031). There is a dose-response relationship between the duration of exposure to SHS and the risk of incident COPD, which demonstrates that an additional hour of exposure to SHS per week was associated with a 1.03-fold increased likelihood of developing COPD after adjusting for confounders (RR = 1.03; 95% CI 1.00 to 1.05; P value = 0.027). SHS exposure contributes to the development of COPD. This finding can help raise awareness of the harms of SHS and provide a reference for formulating anti-smoking policies.

Citing Articles

Lifestyle Factors and Associations with Individual and Comorbid Cardiometabolic and Pulmonary Disease Among U.S. Adults.

Agbonlahor O, Mattingly D, Richardson M, Hart J, McLeish A, Walker K Int J Environ Res Public Health. 2025; 21(12.

PMID: 39767513 PMC: 11675608. DOI: 10.3390/ijerph21121674.


Psychiatric Disorders in Patients with Chronic Obstructive Pulmonary Disease: Clinical Significance and Treatment Strategies.

Moretta P, Cavallo N, Candia C, Lanzillo A, Marcuccio G, Santangelo G J Clin Med. 2024; 13(21).

PMID: 39518558 PMC: 11546101. DOI: 10.3390/jcm13216418.


Comparative Evaluation of Pulmonary Function in Male Street Vendors Versus Smokers: Insights into Occupational and Lifestyle Impact.

Juhi A, Pinjar M, Malik A, Mondal H Maedica (Bucur). 2024; 19(2):312-316.

PMID: 39188827 PMC: 11345072. DOI: 10.26574/maedica.2024.19.2.312.

References
1.
Putcha N, Barr R, Han M, Woodruff P, Bleecker E, Kanner R . Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort. Thorax. 2016; 71:411-420. PMC: 5235992. DOI: 10.1136/thoraxjnl-2015-207487. View

2.
Salvi S . Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease. Clin Chest Med. 2014; 35(1):17-27. DOI: 10.1016/j.ccm.2013.09.011. View

3.
Ho C, Lee J, Huang S, Chen S, Geng J . A Genome-Wide Association Study of Metabolic Syndrome in the Taiwanese Population. Nutrients. 2024; 16(1). PMC: 10780952. DOI: 10.3390/nu16010077. View

4.
Flor L, Anderson J, Ahmad N, Aravkin A, Carr S, Dai X . Health effects associated with exposure to secondhand smoke: a Burden of Proof study. Nat Med. 2024; 30(1):149-167. PMC: 10803272. DOI: 10.1038/s41591-023-02743-4. View

5.
Callinan J, Clarke A, Doherty K, Kelleher C . Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2010; (4):CD005992. DOI: 10.1002/14651858.CD005992.pub2. View